tag drug-repurposing 
Pharma Tutor
OCTOBER 13, 2022
DRUG REPURPOSING : A REVIEW. Read more about DRUG REPURPOSING : A REVIEW Log in or register to post comments Read more about DRUG REPURPOSING : A REVIEW Log in or register to post comments Email : charmiagarwal823@gmail.com. Thu, 10/13/2022 - 15:56. Review Articles.
Rethinking Clinical Trials
JULY 27, 2022
ACTIV-6 is testing medication doses approved by the FDA for other purposes, i.e., repurposed drugs. Given the history with other repurposed drugs, I was concerned people would not want to take Ivermectin. This was one of the reasons we gave people options about which drugs they were willing to take.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
JANUARY 9, 2023
Using gene engineering, we are repurposing cancer cells to develop a therapeutic that kills tumour cells and stimulates the immune system to both destroy primary tumors and prevent cancer.” . Instead of using inactivated tumour cells, the team repurposes living tumour cells, which possess an unusual feature. .
Rethinking Clinical Trials
AUGUST 4, 2022
TOGETHER is a randomized adaptive platform trial that was initiated in June 2020 to investigate the efficacy of repurposed treatments for COVID-19 disease among high-risk adult outpatients. For the countries we are working in this has not been an issue because of the drugs that were available during the time of the study. Key Points.
XTalks
FEBRUARY 27, 2024
There have been significant advancements in new rare disease drugs, particularly for genetic disorders that can be treated by correcting, replacing or silencing defective genes. The US Food and Drug Administration (FDA) has approved a number of new rare disease drugs in recent years, including gene therapies.
The Pharma Data
MARCH 23, 2022
Drugs that target polymerase could potentially treat Ebola virus infections and save lives. Their investigation reveals that an experimental drug that targets GSPT1 for degradation can also halt Ebola virus infection in human cells. Without this information, researchers cannot move forward with structure-based drug design.
pharmaphorum
SEPTEMBER 15, 2020
“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Jeremy Richter, Tag. Joe began his life at Tag in the UK, bringing efficiencies to his clients, working across all conceivable channels.
Expert insights. Personalized for you.
95 
Let's personalize your content